Thursday, March 09, 2017 6:34:22 AM
I thought CTCA http://www.cancercenter.com/ wanted possession of AVAX and complete the trial of O-vax and M-vax. Or sales of patents to other Pharmaceutical Companies.
Last year, I sent email to many Big Pharma to demonstrate the great potential to acquire AVAX for low price, or to enter into partnership.
My hope is that something is happening behind the scenes ...
Maybe someone is trying to buy shares gradually (average of about 200 thousand per day) to avoid the sudden rise in price ...
I'm waiting for the miracle of President Trump to eliminate the FDA bureaucracy!
AVAX on hands of an astute businessman could reach $5 in one night ...
https://www.nytimes.com/2017/02/05/health/with-fda-vacancy-trump-sees-chance-to-speed-drugs-to-the-market.html?_r=0
.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM